IDEX Q2 Earnings Call Highlights

Impact · against what's priced in

IDEX is seeing explosive growth in its Health & Science Technologies segment driven by data centers and semiconductors, which provides strong revenue visibility into 2027. While one-time tariff refunds artificially boosted the current quarter's margins and EPS, the upward revision of full-year guidance and record organic orders signal fundamental strength.

IEX+0.60

No priced-in read yet

In context

Organic orders reached a record $1 billion, with the HST segment growing 47% and demand in data center pneumatics extending into 2027. Despite a $0.08 EPS boost from one-time tariff refunds, the company raised its full-year guidance for sales, margins, and EPS.

Read from the article alone

• earnings▲30%
• guidance▲18%
• aerospace▲4%
• data centers
• semiconductors
• IEX
• defense